Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
URGN
Stock Latest News
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
13d ago
JNJ
CGON
Premium
The Fly
UroGen Pharma announces inducement grants under Nasdaq listing rule
22d ago
URGN
Premium
Company Announcements
UroGen Pharma Shareholders Approve Key Proposals at Meeting
1M ago
8K
URGN
Premium
The Fly
Piper starts ‘underestimated’ UroGen Pharma with an Overweight
1M ago
URGN
Premium
The Fly
UroGen Pharma initiated with an Overweight at Piper Sandler
1M ago
URGN
Premium
Company Announcements
UroGen Pharma’s Earnings Call: Achievements and Challenges
2M ago
URGN
Premium
The Fly
UroGen Pharma price target lowered to $40 from $50 at H.C. Wainwright
2M ago
URGN
Premium
Company Announcements
UroGen Pharma Reports Q2 2025 Results and Launches ZUSDURI
2M ago
URGN
Premium
Ratings
Urogen Pharma’s Strategic Positioning and Growth Potential: Buy Rating Affirmed by Tara Bancroft
2M ago
URGN
Premium
The Fly
UroGen Pharma reports Q2 EPS ($1.05), consensus (83c)
2M ago
URGN
Premium
The Fly
UroGen Pharma announces 24-month DOR for Phase 3 ENVISION trial
2M ago
URGN
Premium
The Fly
UroGen Pharma announces publication of Phase 3b ZUSDURI study results
2M ago
URGN
Premium
The Fly
UroGen Pharma announces five-year long-term extension study of ZUSDURI
2M ago
URGN
Premium
The Fly
UroGen Pharma call volume above normal and directionally bullish
2M ago
URGN
Premium
Ratings
UroGen Pharma’s Promising Outlook: Buy Rating Backed by Clinical Success and FDA Approvals
3M ago
URGN
Premium
The Fly
UroGen Pharma completes enrollment in Phase 3 UTOPIA trial of UGN-103
3M ago
URGN
Premium
Company Announcements
UroGen Pharma Approves Bonuses After FDA Approval
3M ago
8K
URGN
Premium
Weekend Updates
Sweetgreen, Urogen, CoreWeave, Allegro, Dexcom: Trending by Analysts
3M ago
SG
ALGM
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
CEP
RDW
Premium
The Fly
UroGen Pharma upgraded to Buy from Neutral at H.C. Wainwright
4M ago
URGN
Premium
The Fly
UroGen Pharma price target raised to $16 from $3 at Goldman Sachs
4M ago
URGN
Premium
The Fly
UroGen Pharma price target raised to $31 from $10 at Oppenheimer
4M ago
URGN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
